Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03820830
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2019-01-25
Brief Title:
Palbociclib for HR Positive HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-25
First Submit QC Date:
January 25 2019
Study First Post Date:
2019-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-12
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL